Evaluation of a novel intervention to prevent polysubstance overdoses involving illicit stimulants
Evaluation of a novel intervention to prevent polysubstance overdoses involving illicit stimulants
批准号:
10392110
负责人:
Nichole L Michaels
金额:
$72.5万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-09-30 至 2024-09-29
中文摘要
项目摘要
在美国,涉及非法兴奋剂的过量使用正在增加。这些过量中的许多涉及
芬太尼,可在使用者不知情的情况下添加到非法兴奋剂中。鉴于……的效力
芬太尼及其在非法药物供应中的普及性,任何减少过量死亡的有意义的努力
涉及非法兴奋剂的药物也必须涉及芬太尼。芬太尼快速试纸,旨在测试
尿样中存在芬太尼和一些芬太尼类似物,越来越多的人在标签外使用
使用药物在消费前对非法药物进行芬太尼测试的人。这会提醒用户他们可能
希望执行减少过量风险的行为(例如,使用较少的药物)。然而,由于紧急情况
关于这一减少危害战略的性质,同行评议发表的关于这一主题的研究非常有限。这个
拟议的研究针对NOFO的第一个目标,并将测试一项干预措施,以防止
有非法兴奋剂使用史的毒品法庭客户的高危人群。干预措施包括1)
芬太尼试纸教育和分配(FTSED)和2)阿片类药物过量教育和纳洛酮
通过俄亥俄州的毒品法庭进行分销(OEND)。这项研究的长期目标是减少
俄亥俄州和全国与服药过量相关的发病率和死亡率。本研究的研究目标为:1)
确定通过毒品法庭现场提供FTSED和OEND的可接受性和可行性(流程
评估-特定目标1);和2)评估提供FTSED与OEND相结合的影响
与使用非法兴奋剂或包括非法兴奋剂在内的多种物质的毒品法庭客户相比
仅提供OEND(结果评估特定目标2和3)。使用双臂组随机试验
设计时,我们将通过测试以下具体目标来回答研究目标:1)确定
与现场提供FTSED和OEND相关的感知可接受性、障碍和促进因素
向使用非法兴奋剂或包括非法兴奋剂在内的多种物质的客户提供药品法院;2)测试
假设有非法兴奋剂使用史的个人在现场接受FTSED和OEND药物治疗
法院将提高关于如何测试药物芬太尼和策略的知识和自我效能
与那些只接受OEND的人相比,他们降低了过量服药的风险;3)测试以下假设
有非法兴奋剂使用史的个人在毒品法庭现场获得FTSED和OEND将获得
与非法兴奋剂或涉及非法的多物质使用有关的非致命性和致命性过量服药率较低
比那些只接受OEND的人更有刺激性。鉴于芬太尼在非法药物供应中的普遍性,
即使个人的首选药物是非法兴奋剂,也有可能遇到芬太尼和/或芬太尼。
类似物。我们将评估整合的可行性、可接受性以及相关的益处和危害
FTSED进入毒品法庭项目,在一个涉及兴奋剂的过量服药率很高的州。
英文摘要
Project Summary
Overdoses involving illicit stimulants are increasing in the United States (US). Many of these overdoses involve
fentanyl, which may be added to illicit stimulants with or without the user’s knowledge. Given the potency of
fentanyl and its pervasiveness in the illicit drug supply, any meaningful efforts to reduce overdose deaths
involving illicit stimulants must also address fentanyl. Rapid fentanyl test strips, designed to test for the
presence of fentanyl and some fentanyl analogs in urine samples, are increasingly being used off-label by
people who use drugs to test illicit drugs for fentanyl before consumption. This alerts the user that they may
wish to perform overdose risk reduction behaviors (e.g., using less of the drug). However, due to the emergent
nature of this harm reduction strategy, peer-reviewed published research on this topic is very limited. The
proposed study addresses Objective #1 of the NOFO and will test an intervention to prevent overdoses among
a high-risk population of drug court clients with a history of illicit stimulant use. The intervention consists of 1)
fentanyl test strip education and distribution (FTSED) and 2) opioid overdose education and naloxone
distribution (OEND) through drug courts in Ohio. The long-term goal of this research is the reduction of
overdose-related morbidity and mortality in Ohio and nationally. The research objectives of this study are: 1)
Determine the acceptability and feasibility of providing FTSED and OEND on-site through drug courts (process
evaluation – Specific Aim #1); and 2) Evaluate the impact of providing FTSED in combination with OEND to
drug court clients who use illicit stimulants or polysubstances including illicit stimulants, compared with
providing OEND alone (outcome evaluation – Specific Aims #2 & #3). Using a two-arm group randomized trial
design, we will answer the research objectives by testing the following specific aims: 1) Determine the
perceived acceptability, barriers, and facilitating factors associated with providing FTSED and OEND on-site in
drug courts to clients who use illicit stimulants or polysubstances including illicit stimulants; 2) Test the
hypothesis that individuals with a history of illicit stimulant use who receive FTSED and OEND on-site in drug
courts will have improved knowledge and self-efficacy regarding how to test drugs for fentanyl and strategies
for reducing their risk of an overdose compared to those who receive OEND only; 3) Test the hypothesis that
individuals with a history of illicit stimulant use who receive FTSED and OEND on-site in drug courts will have
lower non-fatal and fatal overdose rates associated with illicit stimulants or polysubstance use involving illicit
stimulants than those who receive OEND only. Given the pervasiveness of fentanyl in the illicit drug supply,
even individuals whose preferred drugs are illicit stimulants are likely to encounter fentanyl and/or fentanyl
analogues. We will evaluate the feasibility, acceptability, and associated benefits and harms of integrating
FTSED into drug court programs in a state with high rates of overdoses involving stimulants.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Evaluating the impact of fentanyl test strip use among rural and urban populations
-
批准号:10440481
-
项目类别:
-
资助金额:$68.56万
-
财政年份:2021
-
负责人:Nichole L Michaels
-
依托单位:
Evaluating the impact of fentanyl test strip use among rural and urban populations
-
批准号:10298748
-
项目类别:
-
资助金额:$70.74万
-
财政年份:2021
-
负责人:Nichole L Michaels
-
依托单位:
Evaluation of a novel intervention to prevent polysubstance overdoses involving illicit stimulants
-
批准号:10762925
-
项目类别:
-
资助金额:$72.5万
-
财政年份:2021
-
负责人:Nichole L Michaels
-
依托单位:
Evaluating the impact of fentanyl test strip use among rural and urban populations
-
批准号:10615126
-
项目类别:
-
资助金额:$67.66万
-
财政年份:2021
-
负责人:Nichole L Michaels
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Novel-miR-1134调控LHCGR的表达介导拟
穴青蟹卵巢发育的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:崔文晓
-
依托单位:
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
-
批准号:82304677
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:边兴博
-
依托单位:
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
-
批准号:82304658
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:刘亚
-
依托单位:
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
-
批准号:32102747
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:李婉雁
-
依托单位:
novel_circ_001042/miR-298-5p/Capn1轴调节线粒体能量代谢在先天性肛门直肠畸形发生中的作用机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:唐晓冰
-
依托单位:
novel-miR-59靶向HMGAs介导儿童早衰症细胞衰老的作用及机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:58万元
-
批准年份:2021
-
负责人:张瑜
-
依托单位:
novel_circ_008138/rno-miR-374-3p/SFRP4调控Wnt信号通路参与先天性肛门直肠畸形发生的分子机制研究
-
批准号:82070530
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:白玉作
-
依托单位:
miRNA-novel-272通过靶向半乳糖凝集素3调控牙鲆肠道上皮细胞炎症反应的机制研究
-
批准号:32002421
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:修云吉
-
依托单位:
m6A修饰介导的lncRNA WEE2-AS1转录后novel-pri-miRNA剪切机制在胶质瘤恶性进展中的作用研究
-
批准号:82072775
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:薛皓
-
依托单位:
miRNA/novel_167靶向抑制Dmrt1的表达在红鳍东方鲀性别分化过程中的功能研究
-
批准号:31902347
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2019
-
负责人:闫红伟
-
依托单位: